Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Apr 23, 2019 4:27pm

184 Views

Post# 29661480

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SHORTS COVERED

Longholder99 wrote: I think Ph2 initial results and/or who gets named as our partner for GBM will be accretive and equally effective SP movers. Then we plateau for a bit until the takeover war starts. I dont have any idea where the first plateau will be. Landing 10$+ for those first two catalysts would be reasonable given what's at stake here.

Absolutely, Ph2 first results and brain news will have more weight than ph2 commenecement.
I think we're going to have both plus more soon. Every single morning we wake up, we're one PR away from being extremely happy shareholders.

Bullboard Posts

Changing Europe’s dependency on HREE from China